Literature DB >> 331522

Intraluminal fluorouracil chemotherapy adjunct to surgical procedures for respectable carcinoma of the colon and rectum.

C E Grossi, W I Wolff, T F Nealon, B Pasternack, L Ginzburg, L M Rousselot.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 331522

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


× No keyword cloud information.
  7 in total

1.  5-Fluorouracil as adjuvant chemotherapy for large bowel cancer. Is it appropriate for routine community use?

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 2.  Adjuvant chemotherapy of cancer. A review of its current status.

Authors:  S K Carter
Journal:  Drugs       Date:  1986-04       Impact factor: 9.546

3.  Update in cancer chemotherapy: gastrointestinal cancer--colorectal cancer, Part 2.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-05       Impact factor: 1.798

Review 4.  Systemic treatment of colorectal cancer.

Authors:  Brian M Wolpin; Robert J Mayer
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

Review 5.  Adjuvant therapy for colorectal carcinoma.

Authors:  U Metzger
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

6.  Comparative studies on absorption patterns of the drug after intrarectal administration of 5-FU emulsion and 5-FU solution.

Authors:  S Watanabe; B Nishioka; Y Fujita; T Ueda; O Kojima; K Morisawa; E Yamane; M Umehara; S Majima
Journal:  Jpn J Surg       Date:  1980-06

Review 7.  Adjuvant treatment of colorectal cancer. Current status and concepts.

Authors:  U F Metzger; B C Ghosh; D L Kisner
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.